Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from piper
Reexamination Certificate
2006-02-21
2006-02-21
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from piper
C424S773000, C424S725000
Reexamination Certificate
active
07001620
ABSTRACT:
The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.
REFERENCES:
patent: 3760081 (1973-09-01), Skaletzky
patent: 4154823 (1979-05-01), Schutt
patent: 4248861 (1981-02-01), Schutt
patent: 5178735 (1993-01-01), Manabe et al.
patent: 5234947 (1993-08-01), Cherksey
patent: 5273754 (1993-12-01), Mann
patent: 5296224 (1994-03-01), Schwabe
patent: 5380826 (1995-01-01), Castor et al.
patent: 5389371 (1995-02-01), Shiao
patent: 5401502 (1995-03-01), Wunderlich et al.
patent: 5440055 (1995-08-01), Castor
patent: 5466455 (1995-11-01), Huffstutler, Jr. et al.
patent: 5512285 (1996-04-01), Wilde
patent: 5554382 (1996-09-01), Castor
patent: 5578307 (1996-11-01), Wunderlich et al.
patent: 5585386 (1996-12-01), Rosenbaum
patent: 5639441 (1997-06-01), Sievers et al.
patent: 5698199 (1997-12-01), Mori et al.
patent: 5750709 (1998-05-01), Castor et al.
patent: 5770207 (1998-06-01), Bewicke
patent: 5776486 (1998-07-01), Castor et al.
patent: 5776935 (1998-07-01), Danysz et al.
patent: 5821450 (1998-10-01), Fedida
patent: 5854064 (1998-12-01), Castor et al.
patent: 5877005 (1999-03-01), Castor et al.
patent: 5891465 (1999-04-01), Keller et al.
patent: 5906825 (1999-05-01), Seabrook, Jr.
patent: 5906848 (1999-05-01), Kreuter et al.
patent: 5976550 (1999-11-01), Engel et al.
patent: 5977120 (1999-11-01), Giles, Jr.
patent: 6024998 (2000-02-01), Kreuter et al.
patent: 6025363 (2000-02-01), Giles, Jr.
patent: 6045825 (2000-04-01), Cody
patent: 6068846 (2000-05-01), Cho et al.
patent: 6080410 (2000-06-01), Bewicke
patent: 6095134 (2000-08-01), Sievers et al.
patent: 6117431 (2000-09-01), Ramazanov et al.
patent: 6143300 (2000-11-01), Stevenot
patent: 6159473 (2000-12-01), Watkins et al.
patent: 6174542 (2001-01-01), Hinton et al.
patent: 6207164 (2001-03-01), Kreuter et al.
patent: 6238696 (2001-05-01), Wang
patent: 6238722 (2001-05-01), Meadows
patent: 6241988 (2001-06-01), Erdelmeier et al.
patent: 6280736 (2001-08-01), Erdelmeier et al.
patent: 6288109 (2001-09-01), Chatterjee et al.
patent: 6290985 (2001-09-01), Ream et al.
patent: 6312736 (2001-11-01), Kelly et al.
patent: 6746695 (2004-06-01), Martin et al.
patent: 2002/0192241 (2002-12-01), Chen et al.
patent: 943121 (1963-11-01), None
patent: WO 99/61038 (1999-12-01), None
Avdeef et al. Drug Absorption in Vitro Model: Filter-Immobilized Artificial Membranes: 2. Studies of the Permeability Properties of Lactones in Piper Methysticum Forst.: European Journal of Pharmaceutical Sciences (2001) Jan. 14, pp. 271-280.
Briskin et al. Production of Kavapyrones by Kava (Piper Methysticum) Tissue Cultures: Plant Cell Reports, Sep. 2001, vol. 20, No. 6, pp. 556-561.
Dinh et al. Interaction of Various Piper Methysticum Cultivars with CNS Receptors in Vitro; Planta Medica, Jun. 2001, vol.67, No.4, pp.306-311.
Ganzera et al. Analytical Techniques for the Determination of Lactones in Piper Methysticum Forst.: Chromatographia (1999), 50, 10/11 pp. 649-653.
He et al. Electrospray High Performance Liquid Chromatography Mass Spectrometry in Phytochemical Analysis of Kava (Pipwer Methysticum) Extract: Planta Medica, Feb. 1997, vol. 63, No. 1, pp.70-74.
Segiet-Kujawa et al. Isolation of Kava-Lactones by Rotory Thin Layer Chromatography; Herba Polonica (1999) vol.45, No. 3, pp. 1860191.
Shao et al. Reversed-Phase High-Performance Liquid Chromatographic Method for Quantitative Analysis of the Six Major Kavalactones in Piper Methysticum; Journal of Chromatography A, Oct. 30, 1998, vol. 825, No.1, pp. 1-8.
Smith et al. Anxiolytic Effects of Kava Extract and Kavalactones in the Chick Social Separation-Stress Paradigm; Psychopharmacology, (Apr. 2001) vol. 155, No. 1, pp. 86-90.
Uebelhack et al. Inhibition of Platelet Mao-B by Kava Pyrone-Enriched Extract From Piper Methysticume Forster(Kava-Kava): Phramacopsychiatry, (Sep. 1998) vol. 31, No. 5, pp. 187-192.
Lopez-Avilla, M., and Benedico, J., “Superanneal Fluid Extraction of Kava Lactones from Piper methysticum (Kava) Herb,” J. High Resol Chromatogr., vol. 20, Oct. 1997, pp 555-559.
Ashraf-Khorassant, M., et al., “Supercritical Fluid Extraction of Kava Lactones from Kava Root and Their Separation Via Supercritical Fluid Chromatography,” Chromatographia, vol. 50, No. 5/6, Sep. 1999, pp. 287-292.
Nguyen, U., et al., “Extraction and Fractionation of Spices Using Supercritical Fluid Carbon Dioxide,” Presented at the 5thInternational Symposium on Supercritical Fluids, 1998, Nice, France.
Cappaso, A. et al., Experimental Investigations of the Synergistic-Sedative Effect of Passiflora and Kava, Acta Therapeutica 21, 1995, pp. 127-140, vol. 21, No. 2.
Kubatova, Alena et al., Comparison of Subcritical Water and Organic Solvents for Extracting Kava Lactones from Kava Root, Journal of Chromotography, Jul. 20, 2001, pp. 187-194, vol. 923., No. 1-2, Elsevier Science Publishers B.V. Amsterdam, NL.
Rex, Andre et al., Anxiolytic-Like Effects of Kava-Kava in the Elevated Plus Maze Test-A Comparison with Diazepam, Progress in Neuro-Psychopharacology & Biological Psychiatry, Jun. 2002, pp. 855-860, vol. 26, No. 5.
Williamson, E.M., Synergy and Othe rInteractions in Phytomedicines, Phytomedicine, Sep. 2001, pp. 401-409, vol. 8, No. 5.
Birdsall William
Gow Robert
Pierce Brian
Pierce John
Herbal Science, LLC
Leith Patricia
LandOfFree
Kavalactone product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kavalactone product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kavalactone product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710256